Navigation Links
Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
Date:5/20/2009

duct candidates, the conduct, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009, filed with the SEC on May 11, 2009, as well as other filings by the company with the SEC.

    Contact Information

    US Media:                             European Media:
    Andrea tenBroek/Chris Stamm           Ludger Wess
    (781)-684-0770                  
'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... HACKENSACK, N.J. , July 24, 2015  Champions ... of advanced technology solutions and services to personalize the ... will report its financial and operational results for the ... 2015, on Tuesday, July 28, 2015, before market open. ... to discuss the results that day at 9:00 a.m. ...
(Date:7/24/2015)... ... July 24, 2015 , ... ... management solution, indispensable to any modern scientific or pharmaceutical laboratory. FreezerPro® is ... interface. Users know precisely where a sample is located even before opening ...
(Date:7/23/2015)... , July 23, 2015 The Hong ... been given the prestigious accolade of "Most Innovative ... its world-class position in fostering innovation and technology ... Asia-Pacific region.  The award ... UK-based innovation and technology magazine and website with ...
(Date:7/23/2015)... 23, 2015 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... immunotherapies, invites investors and the general public to its ... on Friday, July 31, 2015. The meeting will be ... Room, San Diego, California 92121. ... will also be available. Please use the following link ...
Breaking Biology Technology:Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 2HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 3OncoSec to Webcast Annual Meeting of Stockholders 2
... Inc.,( http://www.nikoninstruments.com/ ) announced its new SMZ-445/460,stereoscopic zoom ... at a low cost for the Industrial and ... range of applications, from routine,quality control to semiconductor ... to 3.5x zoom magnification, and SMZ-460, 0.7x to,3.0x ...
... SAFE-BioPharma Association First to Offer TriCipher ID Tool ToGo ... Pharmaceutical and ... TriCipher, the strong,authentication company, has created the first SAFE-BioPharma(TM) ... Key Infrastructure,Policy Authority (FPKIPA), the interagency body that enforces ...
... 15, Agendia BV and Ferrer inCode today announced ... sell two of Agendia,s,signature cancer diagnostic services -- ... to indicate risk of breast cancer tumor,recurrence, and ... fast and reliable method of identifying the primary ...
Cached Biology Technology:Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 3TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 4Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 2Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 3
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... NEW YORK (FEBRUARY 13, 2008) The Wildlife Conservation ... a 5,000 mile-long genetic corridor from Bhutan to Burma ... landscapes. The corridor, first announced at the United Nations ... the largest block of tiger habitat left on earth. ...
... group of the University of Granada has found ... and the olive skin wax extracted from alpeorujo (crushed olive ... regulating apoptosis in carcinogenic processes., Maslinic acid is a protease ... cell growth. It is useful for cancer treatment, as it ...
... snuggle can prematurely end a love affair, as new evidence ... a smokers risk of an early heart attack. Researchers say ... population has a gene defect that delivers a one-two punch ... with this common gene variant experienced a heart attack around ...
Cached Biology News:'Genetic corridors' are next step to saving tigers 2'Genetic corridors' are next step to saving tigers 3A compound extracted from olives inhibits cancer cells growth and prevents their appearance 2Cigarette after Valentine snuggle deadlier for some 2Cigarette after Valentine snuggle deadlier for some 3
MOUSE ANTI RABBIT T LYMPHOCTYES Immunogen: Rabbit Thymocytes...
Normal canine serum collected from healthy normal canines....
RABBIT ANTI HUMAN CYTOCHROME P450 1A1/2 Immunogen: Purified human CYP1A2 expressed in E.Coli ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Biology Products: